Risk of Malignancy Can Be Quantified Using Simple Rules

This article originally appeared here.
Share this content:
Risk of Malignancy Can Be Quantified Using <i>Simple Rules</i>
Risk of Malignancy Can Be Quantified Using Simple Rules

TUESDAY, Jan. 26, 2016 (HealthDay News) -- Use of ultrasonography features can help identify the risk of malignancy for patients with an adnexal tumor, according to a study published online Jan. 18 in the American Journal of Obstetrics & Gynecology.

Dirk Timmerman, M.D., Ph.D., from KU Leuven in Belgium, and colleagues developed and validated a model to predict the risk of malignancy in adnexal masses using the ultrasound features in the Simple Rules algorithm. Data were included for 4,848 patients with an adnexal tumor from 22 oncology centers, referral centers for ultrasonography, and general hospitals.

The researchers found that the malignancy rates were 43 and 17 percent, respectively, in oncology centers and other centers (area under the receiver operating characteristic curve on validation data, 0.917 and 0.916, respectively). Good calibration was seen in risk estimates. In the validation data set, 23 percent of patients had a very low estimated risk (<1 percent) and 48 percent had high estimated risk (≥30 percent). Sensitivity and specificity were 99.7 and 33.7 percent, respectively, for the 1 percent risk cut-off, with positive and negative predictive values (PPV and NPV) of 44.8 and 98.9 percent, respectively. Sensitivity and specificity were 89.0 and 84.7 percent, respectively, for the 30 percent risk cut-off, with PPV and NPV of 75.4 and 93.9 percent.

"Quantification of the risk of malignancy based on the Simple Rules has good diagnostic performance both in oncology centers and other centers," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin

More Evidence HPV Vaccine Protects Against Cervical Cancer

More Evidence HPV Vaccine Protects Against Cervical Cancer

Protection appears to occur even when only one or two of the recommended doses are given

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Study of millions of health records suggests an association

is free, fast, and customized just for you!

Already a member?

Sign In Now »